Axsome Therapeutics (AXSM) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of$1. This compares to a loss of $1.24 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +8.00$1.26 per share when it actually produced a loss of $0.8, delivering a surprise of +36.51%. Over the last four quarters, t ...